The calcimimetic agents: Perspectives for treatment

Kidney International, Supplement

Volumn 61, Issue 80, 2002, Pages S149-S154

  Frazão, João M ^a,b   Martins, Patrícia ^a,b   Coburn, Jack W ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood ionized calcium; Calcimimetics; Calcium X phosphorus product; Calcium sensing receptor; Parathyroid carcinoma; Phosphorus levels; Primary hyperparathyroidism; Review; Secondary hyperparathyroidism

Indexed keywords

CALCIUM BINDING PROTEIN; CALCIUM SENSING RECEPTOR; CELL SURFACE RECEPTOR; ADENYLATE CYCLASE; ARACHIDONIC ACID; CALCIUM CHANNEL STIMULATING AGENT; CALCIUM ION; CINACALCET; CYCLIC AMP; CYTOCHROME P450; FUROSEMIDE; MESSENGER RNA; PAMIDRONIC ACID; PARATHYROID HORMONE; PHOSPHOLIPASE C; R 568; SALCATONIN; UNCLASSIFIED DRUG;

DRUG EFFECT; HUMAN; KIDNEY; PHYSIOLOGY; REVIEW; SECONDARY HYPERPARATHYROIDISM; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HEMODIALYSIS; HYPERCALCEMIA; HYPERPHOSPHATEMIA; KIDNEY FAILURE; MUTATION; NONHUMAN; PARATHYROID CARCINOMA; PARATHYROID HORMONE RELEASE; PHOSPHATE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RECEPTOR AFFINITY; TREATMENT OUTCOME;

CALCIUM-BINDING PROTEINS; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY; RECEPTORS, CALCIUM-SENSING; RECEPTORS, CELL SURFACE;

EID: 0035999938     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.61.s80.25.x     Document Type: Article

References (35)

1. 2+ and other ions as extracellular (first) messengers
2. 2+-sensing receptor from bovine parathyroid
3. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism
4. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe-hyperparathroidism
5. Three inherited disorders of calcium sensing
6. 2+-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism
7. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor
8. 2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568
9. The extracellular calcium-sensing receptor: Its role in health and disease
10. Extracellular calcium-sensing receptor: Implications for calcium and magnesium handling in the kidney
11. Physiology and pathophysiology of the extracellular calcium-sensing receptor
12. The influence of hypermagnesemia on serum calcium and parathyroid hormone in human subjects
13. Effect of hypercalcemia on renal tubular handling of calcium and magnesium
14. Control of magnesium transport in the thick ascending limb
15. Calcium-receptor-regulated parathyroid and renal function
16. 2+/polyvalent cation-sensing protein in rat kidney
17. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct
18. 3 by calcium in the parathyroidectomized, parathyroid hormone-replete rat
19. 2+-sensing receptor in rat intestine
20. Localization of calcium receptor mRNA in the adult rat central nervous system by in situ hybridization
21. Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells
22. i signaling expressed by GCT23 osteoclast-like cells
23. Cation sensing receptors in bone: A novel paradigm for regulating bone remodeling?
24. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism
25. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism
26. 3
27. Rat calcium sensing receptor is regulated by vitamin D but not by calcium
28. 2+ receptor mRNA and protein increase in the rat parathyroid gland with advancing age
29. Reduced expression of the renal calcium-sensing receptor in rats with experimental chronic renal insufficiency
30. Calcimimetics with potent and selective activity on the parathyroid calcium receptor
31. Tricking the parathyroid gland with novel calcimimetic agents
32. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent
33. A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure
34. A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism
35. Short-term inhibition of parathyroid hormone secretion by a calcium receptor agonist in primary hyperparathyroidism